18th September 2019
"The Nordics are a very enabling ecosystem; many stakeholders are travelling in the same direction as us to support VBHC."
Ingeborg R. Borgheim holds a senior leadership position at Takeda and leads the Nordic Region. We spoke to Ingeborg at eyeforpharma, Barcelona…
12th April 2019
“We all need a North Star: to keep us true, on track, inspired, and working tirelessly towards what we want to achieve”
Jennifer Turgiss leads the behaviour science and analytics teams at Johnson & Johnson (J&J), applying her expertise in behavioural and social science to develop digital health behaviour change interventions. We spoke to Jennifer at this year’s eyeforpharma, Barcelona on her long-standing career in the Health and Wellness industry and scaling bespoke patient behaviour change programmes.
3rd April 2019
“Medical Affairs has a Central Role to Play in Building Trust Between Doctors and Healthcare Stakeholders and the Pharmaceutical Industry”
Cesar Sanz Rodriguez is Associate Vice President, Medical Affairs Lead Mid-Europe (MER), Eastern Europe, Middle East & Africa (EEMEA) Regions. He spoke to us about his progression into medical affairs from a clinical background, the changing role of medical affairs in the pharma industry, and the exciting advances currently taking place in cancer treatment.
20th March 2019
“For us it’s about more than just selling the products – we want to be a responsible partner in society”
Karsten Lollike is the Corporate Vice President and the Qualified Person Responsible for Pharmacovigilance (QPPV) of Global Safety at Novo Nordisk, a position he has held for 11 years. Dr. Lollike joined Novo Nordisk in 2000, working in Global Development in Haemostasis, after obtaining his medical degree and subsequently a PhD. We spoke to Dr. Lollike about his medical expertise and experience, his long-standing career at Novo Nordisk, and what working at the company means to him.